文献速递白内障与屈光手术

LncRNA PLCD3-OT1作为ceRNA吸附miR-224-5p调控PLCD3表达防止年龄相关性白内障

LncRNA PLCD3-OT1 Functions as a CeRNA to Prevent Age-Related Cataract by Sponging miR-224-5p and Regulating PLCD3 Expression.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2019-01-01

该研究对年龄相关性白内障(ARC)组与年龄匹配组的晶状体囊膜进行高通量RNA测序,分析lncRNA表达谱,并在临床样本和细胞模型中验证。发现ARC中lncRNA PLCD3-OT1与PLCD3表达显著降低,PLCD3-OT1过表达可促进PLCD3表达、细胞活力和增殖并抑制氧化应激下凋亡,其机制为作为ceRNA竞争结合miR-224-5p调控PLCD3。

要点

  • ARC中lncRNA PLCD3-OT1与PLCD3表达显著降低。
  • PLCD3-OT1过表达促进PLCD3表达、细胞活力和增殖,抑制氧化应激下凋亡。
  • PLCD3-OT1作为ceRNA竞争结合miR-224-5p调控PLCD3。

核心结论

  • PLCD3-OT1和PLCD3可能成为ARC预后、诊断和治疗的潜在靶点。

研究设计与样本

  • 对ARC组与年龄匹配组的晶状体囊膜进行高通量RNA测序分析lncRNA表达谱。
  • 在临床样本和细胞模型中用实时PCR检测lncRNA和mRNA表达模式。
  • 采用CCK-8、EdU、TUNEL和PI染色检测细胞活力、增殖、凋亡和细胞周期。
  • 用荧光原位杂交检测lncRNA定位,双荧光素酶报告分析验证ceRNA机制。

主要发现

  • ARC中lncRNA PLCD3-OT1和PLCD3表达显著降低。
  • PLCD3-OT1过表达促进PLCD3表达、细胞活力和增殖,抑制氧化应激下细胞凋亡。
  • 敲低PLCD3显示与PLCD3-OT1过表达相反的结果。
  • PLCD3-OT1通过正向调控PLCD3表达发挥作用。
  • PLCD3-OT1可能作为ceRNA通过竞争miR-224-5p调控PLCD3表达。

临床怎么用

  • PLCD3-OT1和PLCD3可作为ARC潜在预后、诊断和治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Long noncoding RNAs (lncRNAs) are important in disease progression and cellular functions. This study aimed to conduct global lncRNA profiling and characterize the role of lncRNA 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase delta 3-sence RNA 1 (PLCD3-OT1) in the progression of age-related cataract (ARC). METHODS: We performed lncRNA expression profiling of lens capsule from ARC groups and age-matched groups using high-throughput RNA-sequencing. Real-time PCR was conducted to detect the expression pattern of lncRNA and mRNA in the clinical samples and cell model. Assays of cell-counting kit-8, 5'-ethynyl-2'-deoxyuridine, TUNEL, and propidium iodide staining were used to detect cell viability, proliferation, apoptosis, and cell cycle. We also performed fluorescence in situ hybridization assay to detect the location of lncRNA, and verified the endogenous competitive RNA mechanism between miRNAs, lncRNAs, and target genes via double-luciferase reporter analyses. RESULTS: The expression of lncRNA PLCD3-OT1 and PLCD3 were significantly decreased in ARC. PLCD3-OT1 overexpression promoted the expression of PLCD3, cell viability, proliferation, and inhibited cell apoptosis upon oxidative stress, while knockdown of PLCD3 showed the opposite results. Mechanistically, PLCD3-OT1functions through positively regulation the expression of PLCD3. In addition, PLCD3-OT1 may act as a ceRNA to regulate the expression of PLCD3 through competition for miR-224-5p. CONCLUSIONS: PLCD3-OT1 and PLCD3 may become potential therapeutic targets for the prognosis, diagnosis, and treatment of ARC.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Xiang J, Chen Q, Kang L, et al. LncRNA PLCD3-OT1 Functions as a CeRNA to Prevent Age-Related Cataract by Sponging miR-224-5p and Regulating PLCD3 Expression. Invest Ophthalmol Vis Sci. 2019. PMID: 31725166. doi:10.1167/iovs.19-27211

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。